Cargando…

Dual Regulation of miR-34a and Notch Signaling in Triple-Negative Breast Cancer by Antibody/miRNA Nanocarriers

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks expression of the three most common receptors present on other subtypes, leaving it unsusceptible to current targeted or hormonal therapies. In this study, we introduce an alternative treatment strategy for TNB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valcourt, Danielle M., Day, Emily S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332498/ https://www.ncbi.nlm.nih.gov/pubmed/32622330 http://dx.doi.org/10.1016/j.omtn.2020.06.003

Ejemplares similares

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
por: Chim, Chor Sang, et al.
Publicado: (2011)

Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression
por: Aherne, Sinéad T, et al.
Publicado: (2015)

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients
por: Svoboda, Marek, et al.
Publicado: (2012)

Notch1 in Tumor Microvascular Endothelial Cells and Tumoral miR-34a as Prognostic Markers in Locally Advanced Triple-Negative Breast Cancer
por: Kim, Dongmin, et al.
Publicado: (2019)

miR-34 miRNAs provide a barrier for somatic cell reprogramming
por: Choi, Yong Jin, et al.
Publicado: (2011)

miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110
por: Song, Rui, et al.
Publicado: (2014)

miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer
por: Kong, Peng, et al.
Publicado: (2018)

S-Adenosylmethionine Inhibits Cell Growth and Migration of Triple Negative Breast Cancer Cells through Upregulating MiRNA-34c and MiRNA-449a
por: Coppola, Alessandra, et al.
Publicado: (2020)

LncRNA PAPAS may promote triple-negative breast cancer by downregulating miR-34a
por: Kong, Yan, et al.
Publicado: (2019)

Expression of Bioinformatically Candidate miRNAs including, miR-576-5p, miR-501-3p and miR-3143, Targeting PI3K Pathway in Triple-Negative Breast Cancer
por: Hadavi, Razie, et al.
Publicado: (2019)

Inhibition of miRNA-34a promotes triple negative cancer cell proliferation by promoting glucose uptake
por: Li, Zhen, et al.
Publicado: (2019)

MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions
por: Shi, Zhendong, et al.
Publicado: (2017)

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
por: Fkih M’hamed, Insaf, et al.
Publicado: (2015)

A Presenilin/Notch1 pathway regulated by miR-375, miR-30a, and miR-34a mediates glucotoxicity induced-pancreatic beta cell apoptosis
por: Li, Yating, et al.
Publicado: (2016)

Quantitative Proteomic Analysis of Gene Regulation by miR-34a and miR-34c
por: Ebner, Olivia A., et al.
Publicado: (2014)

PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a
por: Huang, Xiaojia, et al.
Publicado: (2017)

miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer
por: Martini, Silvia, et al.
Publicado: (2021)

A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression
por: Okada, Nobuhiro, et al.
Publicado: (2014)

The Dual Role of miR-186 in Cancers: Oncomir Battling With Tumor Suppressor miRNA
por: Xiang, Ying, et al.
Publicado: (2020)

Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance
por: Patutina, Olga, et al.
Publicado: (2020)

Downregulation of miRNA miR-1305 and upregulation of miRNA miR-6785-5p may be associated with psoriasis
por: Yan, Jianjun, et al.
Publicado: (2022)

Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA
por: Kang, Min, et al.
Publicado: (2020)

Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates
por: Bertoli, Gloria, et al.
Publicado: (2021)

MiR-34c represses muscle development by forming a regulatory loop with Notch1
por: Hou, Lianjie, et al.
Publicado: (2017)

Regulation of podocyte lesions in diabetic nephropathy via miR-34a in the Notch signaling pathway
por: Zhang, Xiangying, et al.
Publicado: (2016)

Aberration methylation of miR-34b was involved in regulating vascular calcification by targeting Notch1
por: Lin, Xiao, et al.
Publicado: (2019)

MiRNA-34 and stress response
por: Andolina, Diego, et al.
Publicado: (2016)

miR-34a screened by miRNA profiling negatively regulates Wnt/β-catenin signaling pathway in Aflatoxin B1 induced hepatotoxicity
por: Zhu, Liye, et al.
Publicado: (2015)

miRNA‐34c Suppresses Osteosarcoma Progression In Vivo by Targeting Notch and E2F
por: Bae, Yangjin, et al.
Publicado: (2022)

MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas
por: Kim, Jeong Seon, et al.
Publicado: (2019)

Analysis of the miR-34 family functions in breast cancer reveals annotation error of miR-34b
por: Engkvist, M. E., et al.
Publicado: (2017)

Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer
por: Gibori, Hadas, et al.
Publicado: (2018)

Expression patterns of seven key genes, including β-catenin, Notch1, GATA6, CDX2, miR-34a, miR-181a and miR-93 in gastric cancer
por: Jafari, Narjes, et al.
Publicado: (2020)

Synergistic anticancer effects of nanocarrier loaded with berberine and miR-122
por: Li, Lei, et al.
Publicado: (2018)

Bioinformatic miRNA-mRNAs Analysis Revels to miR-934 as a Potential Regulator of the Epithelial–Mesenchymal Transition in Triple-Negative Breast Cancer
por: Contreras-Rodríguez, Jorge Alberto, et al.
Publicado: (2023)

miR-34: from bench to bedside
por: Agostini, Massimiliano, et al.
Publicado: (2014)

MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma
por: Vychytilova-Faltejskova, Petra, et al.
Publicado: (2015)

circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a
por: He, Rongfang, et al.
Publicado: (2017)

Nanodiamond-based layer-by-layer nanohybrids mediate targeted delivery of miR-34a for triple negative breast cancer therapy
por: Xia, Yang, et al.
Publicado: (2018)

LncRNA FEZF1-AS1 Sponges miR-34a to Upregulate Notch-1 in Glioblastoma
por: Luo, Lun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rlkahpnjoeekd58r889k3flhjq